Last reviewed · How we verify

NCT03346460

Effect of Photodymamic Therapy With Urucum and LED in the Reduction of Halitosis

Status unknown Phase 2 Last updated 4 May 2018
What this trial tests

Phase 2 trial testing Tongue Scraping in Halitosis in 45 participants. Status unknown.

Timeline
5 March 2018
Primary endpoint
5 December 2018
5 December 2018

Quick facts

Lead sponsorUniversity of Nove de Julho
PhasePhase 2
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment45
Start date5 March 2018
Primary completion5 December 2018
Estimated completion5 December 2018
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of Nove de Julho

Who can join

Adults 18 to 25, any sex, with Halitosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Halitosis, also known as bad breath, is a term used to define an unpleasant and foul odor that emanates from the mouth and may have local or systemic origin. This project aims to observe the presence of halitosis and to verify if the treatment with antimicrobial photodynamic therapy (aPDT) is effective against it. The investigators will select 45 students or UNINOVE employees, from 18 to 25 years old, with a diagnosis of halitosis, presenting sulfite (SH2) ≥ 112 ppb on gas chromatography. Patients will be randomly divided into 3 groups of 15, which will receive different treatments: Group 1: treatment with tongue scraper; Group 2: aPDT applied in the back region and middle third of the tongue; Group 3: combined treatment of tongue scraper and aPDT. For the aPDT we will use urucum manipulated in the concentration of 20% (Fórmula e Ação®) in spray, to be applied in sufficient quantity to cover the middle third and back of the tongue (5 sprinkles) for 5 minutes for incubation, associated with a LED (Valo Cordless Ultradent®). 6 points will be irradiated on the back of the tongue with a distance of 1 cm between the points, considering the halo of light scattering and effectiveness of aPDT. The apparatus shall be precalibrated at wavelength 440-480nm for 60 seconds per point, irradiance of 450mW/cm and the light shall be irradiated so that a halo of 2cm diameter is formed per point. The results of the halimetry will be compared before and immediately after the treatment, besides the microbiological analysis of the tongue coating, before and after the treatment. The normality of the data will be measured using the Shapiro-Wilk test, and in the case of normality the Variance Analysis (ANOVA) test will be applied, and in the case of non-parametric data, the Kruskal-Wallis test will be used. To analyze the results of each treatment in both periods of the study, the Wilcoxon test will be used.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Interventions for managing halitosis.
    Kumbargere Nagraj S, Eachempati P, Uma E, Singh VP, et al · · 2019 · cited 29× · PMID 31825092 · DOI 10.1002/14651858.cd012213.pub2
  2. Photodynamic therapy with Bixa orellana extract and LED for the reduction of halitosis: study protocol for a randomized, microbiological and clinical trial.
    Gonçalves MLL, da Mota ACC, Deana AM, Guedes GH, et al · · 2018 · cited 8× · PMID 30373650 · DOI 10.1186/s13063-018-2913-z

Verify or expand the search:

Other trials of Tongue Scraping

Trials testing the same drug.

Other recruiting trials for Halitosis

Currently open trials in the same condition.

Other University of Nove de Julho trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03346460.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing